Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

566.00p
   
  • Change Today:
    -5.00p
  • 52 Week High: 578.00
  • 52 Week Low: 232.50
  • Currency: UK Pounds
  • Shares Issued: 120.17m
  • Volume: 101,891
  • Market Cap: £680.18m
  • RiskGrade: 125

Latest ShareCast News

RBC Capital Markets raises target price on OXB

By Iain Gilbert

Date: Tuesday 26 Aug 2025

(Sharecast News) - Analysts at RBC Capital Markets hiked their target price on gene and cell therapy firm OXB from 800p to 930p on Tuesday following its recent oversubscribed £60m equity funding and revenue guidance reiteration.

Oxford Biomedica raises £60m to bolster US capacity

By Benjamin Chiou

Date: Friday 15 Aug 2025

(Sharecast News) - Oxford Biomedica has raised £60m via a share placing and subcription to expand its US operations, the gene and cell therapy company announced on Friday.

Oxford Biomedica agrees new four-year, $125m loan facility

By Josh White

Date: Friday 01 Aug 2025

(Sharecast News) - Oxford Biomedica announced on Friday that it has agreed a new four-year loan facility of up to $125m with Oaktree Capital Management, refinancing its existing debt and providing additional funding capacity to support future expansion.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 566.00p
Change Today -5.00p
% Change -0.88 %
52 Week High 578.00
52 Week Low 232.50
Volume 101,891
Shares Issued 120.17m
Market Cap £680.18m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average
17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average
Price Trend
84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average
86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average
Income Not Available
Growth
5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average
24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 29-Aug-2025

Time Volume / Share Price
16:35 252 @ 566.00p
16:35 15,574 @ 566.00p
16:35 73 @ 566.00p
16:35 50 @ 566.00p
16:35 46 @ 566.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page